1. Home
  2. KZIA vs SOAR Comparison

KZIA vs SOAR Comparison

Compare KZIA & SOAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KZIA
  • SOAR
  • Stock Information
  • Founded
  • KZIA 1994
  • SOAR 2021
  • Country
  • KZIA Australia
  • SOAR United States
  • Employees
  • KZIA N/A
  • SOAR N/A
  • Industry
  • KZIA Biotechnology: Pharmaceutical Preparations
  • SOAR Blank Checks
  • Sector
  • KZIA Health Care
  • SOAR Finance
  • Exchange
  • KZIA Nasdaq
  • SOAR Nasdaq
  • Market Cap
  • KZIA 7.8M
  • SOAR 9.3M
  • IPO Year
  • KZIA 1999
  • SOAR N/A
  • Fundamental
  • Price
  • KZIA $1.42
  • SOAR $0.21
  • Analyst Decision
  • KZIA Strong Buy
  • SOAR
  • Analyst Count
  • KZIA 1
  • SOAR 0
  • Target Price
  • KZIA $20.00
  • SOAR N/A
  • AVG Volume (30 Days)
  • KZIA 116.4K
  • SOAR 2.9M
  • Earning Date
  • KZIA 11-15-2024
  • SOAR 11-18-2024
  • Dividend Yield
  • KZIA N/A
  • SOAR N/A
  • EPS Growth
  • KZIA N/A
  • SOAR N/A
  • EPS
  • KZIA N/A
  • SOAR N/A
  • Revenue
  • KZIA $1,655,324.00
  • SOAR $102,271,000.00
  • Revenue This Year
  • KZIA $806.89
  • SOAR N/A
  • Revenue Next Year
  • KZIA N/A
  • SOAR N/A
  • P/E Ratio
  • KZIA N/A
  • SOAR N/A
  • Revenue Growth
  • KZIA 248000.00
  • SOAR 97.25
  • 52 Week Low
  • KZIA $1.39
  • SOAR $0.17
  • 52 Week High
  • KZIA $15.80
  • SOAR $4.50
  • Technical
  • Relative Strength Index (RSI)
  • KZIA 20.74
  • SOAR 42.74
  • Support Level
  • KZIA $1.42
  • SOAR $0.19
  • Resistance Level
  • KZIA $1.89
  • SOAR $0.29
  • Average True Range (ATR)
  • KZIA 0.24
  • SOAR 0.03
  • MACD
  • KZIA 0.02
  • SOAR -0.00
  • Stochastic Oscillator
  • KZIA 1.40
  • SOAR 21.08

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.

About SOAR Volato Group Inc.

Volato Group Inc operates an aircraft ownership program, provides ad-hoc charter flights, sells deposit products, and manages aircraft for owners in the private aviation industry. It offers fractional ownership, aircraft management, jet cards, deposit, and charter programs. The company's fractional programs provides flexible hours and a revenue share for owners in a fleet of HondaJets, optimized for missions of up to four passengers.

Share on Social Networks: